REQUITE aims to develop validated clinical models and incorporate biomarkers to identify before treatment cancer patients at risk of side-effects and use the models to design interventional trials aimed at reducing side-effects and improving QoL in cancer survivors who underwent radiotherapy

REQUITE will:

1. carry out a multi-centre, obeservational study to collect standardised data and samples in breast, prostate and lung cancer patients;

2. validate biomarkers with published evidence of predictive value;

3. replicate published clinical models and incorporate replicated biomarkers to create validated predictive algorithms;

4. use the prospectively validated models and biomarkers to design interventional trial protocols aiming to reduce side-effects and improve QoL in high-risk patients.